Oral Contraceptives
Are Some Birth Control Pills Too Risky?
Some birth control pills have been shown to lead to an increased risk for adverse events. Some, like Yaz, Yasmin, and Beyaz, were required to add labels. Read more to find out what else you need to know.
Oral Contraceptives
Are Some Birth Control Pills Too Risky?
Some birth control pills have been shown to lead to an increased risk for adverse events. Some, like Yaz, Yasmin, and Beyaz, were required to add labels. Read more to find out what else you need to know.
Oral Contraceptives
Are Some Birth Control Pills Too Risky?
Some birth control pills have been shown to lead to an increased risk for adverse events. Some, like Yaz, Yasmin, and Beyaz, were required to add labels. Read more to find out what else you need to know.
Are Some Birth Control Pills Too Risky?
Some birth control pills have been shown to lead to an increased risk for adverse events. Some, like Yaz, Yasmin, and Beyaz, were required to add labels. Read more to find out what else you need to know.
Are Some Birth Control Pills Too Risky?
Some birth control pills have been shown to lead to an increased risk for adverse events. Some, like Yaz, Yasmin, and Beyaz, were required to add labels. Read more to find out what else you need to know.
be your own reproductive health advocate
FDA Actions
With Doubts, FDA Panel Votes For Yaz and Related Contraceptives
NPR, 2011. Doubts have been growing about Yasmin, Yaz and their sister contraceptives for several years now. And those doubts reached full flower at a Food Drug Administration advisory panel on Thursday.
FDA Panels: Too Many Conflicts or Too Little Expertise?
The number of FDA advisory committee members with conflict of interest waivers is lower than ever, but many members still show clear bias in favor of approving drugs and medical devices that are not proven safe or not proven effective.
How to Report Problems with Medical Problems to the FDA
Have you or someone you know been harmed by medical devices? Here is how to make a report to the FDA.